Amylyx Pharmaceuticals, Inc. Securities Litigation
Checked October 15, 2026 against the official notice · Edited by Ferhat Abdullahoglu
This settlement closed on August 31, 2026
If you filed, payments follow the court's final approval (hearing September 10, 2026).
If you purchased or acquired Amylyx Pharmaceuticals, Inc. securities between November 11, 2022, and November 8, 2023, you may be eligible for a payment from a $6.5 million settlement fund. Your payment amount will depend on your recognized losses, the number of valid claims filed, and deductions for attorneys' fees and expenses, meaning the amount can go up or down.
Who qualifies
- Between November 11, 2022 and November 8, 2023.
- Anywhere in the United States.
- Products: Amylyx securities.
“The Settlement Class consists of all those who purchased or otherwise acquired Amylyx securities between November 11, 2022, and November 8, 2023, inclusive, and who were damaged thereby.”From the court-approved notice
What you can get
Cash payment
shared pro rata from $6,500,000 fund
Proof: Documentation of purchases and sales of Amylyx securities
What proof means here: Documentation of all purchases and sales of Amylyx securities during the Settlement Class Period.
These are the amounts the settlement publishes. Shares of a fund depend on how many people file: what pro rata means.
How to file
The claim deadline has passed. If you filed, payments follow the court's final approval.
Key dates
When settlements pay, and what can delay it.
Is this settlement legit?
Yes. It's a court-approved class action settlement in the United States District Court for the District of Massachusetts (case 1:24-cv-12068-NMG), run by Strategic Claims Services. The official site is strategicclaims.net. You never pay to file a claim. How to check a settlement notice.
Related settlements
ClaimWell summarizes the official notice so it's easier to read. It isn't legal advice; the official settlement site is the authority on who qualifies and what each claim pays.